Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02353806Phase 4Completed
Phase 4, open-label, single-arm trial of amlodipine in hypertension (HTN), sponsored by UT Southwestern Medical Center. Primary endpoints: Area Under the Curve for Amlodipine in Maternal Serum at 24 hours, Time to Maximal Concentration in Maternal Serum at 24 hours and 6 more. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02353806.